Today, significant advances in medicine are achieved through collaborative efforts of pharmaceutical and biotech companies, academic and government institutions, independent research firms, information technology vendors, payers, providers, and industry regulators. For example, biotech and pharmaceutical partnerships are providing Big Pharma with opportunities to expand product pipelines and biotech companies with tried and true manufacturing and marketing capacity. Such partnerships and alliances have proven critical to the success of the biotech industry. In fact, biotech companies engaged in more than 1,000 partnerships, mergers, and acquisitions with pharmaceutical companies and other biotech companies in 2007, according to Biotechnology Industry Organization (BIO).

Esperion understands the significant research, manufacturing, testing, product management, and marketing resources required to transform a portfolio of product candidates into new drugs for the worldwide market . Our collaborations can take the form of research partnerships, licensing agreements, clinical testing and manufacturing alliances, and more. We recognize the value provided by business partners and appreciate just how important collaboration is to achieving success in today's marketplace.

Esperion requires excellence in science and solid business fundamentals in its partners. In return, Esperion provides deep expertise and credibility, speed and efficiency, and a track record of success. If you're interested in exploring collaboration opportunities with Esperion, please contact us at 734-862-4840. Together we can translate the remarkable pace of today's biotechnology advances into therapies that make a difference in patients' lives.